Procter & Gamble (NYSE:PG) Price Target Raised to $165.00

Procter & Gamble (NYSE:PGFree Report) had its price objective upped by Stifel Nicolaus from $161.00 to $165.00 in a report issued on Thursday,Benzinga reports. They currently have a hold rating on the stock.

PG has been the topic of a number of other research reports. JPMorgan Chase & Co. cut their price target on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating on the stock in a report on Thursday, January 16th. DA Davidson reissued a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a research note on Thursday. Wells Fargo & Company upped their price target on Procter & Gamble from $176.00 to $180.00 and gave the company an “overweight” rating in a research report on Thursday. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a research report on Monday, October 21st. Finally, Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Eight equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $180.53.

View Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Stock Down 1.0 %

PG opened at $164.41 on Thursday. Procter & Gamble has a 12 month low of $152.06 and a 12 month high of $180.43. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.49. The business’s 50-day moving average price is $168.85 and its 200-day moving average price is $169.34. The company has a market cap of $387.20 billion, a P/E ratio of 26.18, a P/E/G ratio of 3.69 and a beta of 0.45.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.88% and a net margin of 18.35%. The business had revenue of $21.88 billion for the quarter, compared to analysts’ expectations of $21,657,595.49 billion. During the same period in the previous year, the firm earned $1.84 EPS. The business’s quarterly revenue was up 2.1% on a year-over-year basis. On average, equities analysts expect that Procter & Gamble will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th will be issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.45%. The ex-dividend date of this dividend is Friday, January 24th. Procter & Gamble’s payout ratio is 64.17%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now owns 11,595 shares of the company’s stock, valued at approximately $2,002,804.35. This trade represents a 52.47 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.18% of the stock is owned by insiders.

Institutional Investors Weigh In On Procter & Gamble

Several institutional investors and hedge funds have recently added to or reduced their stakes in PG. RPg Family Wealth Advisory LLC purchased a new position in Procter & Gamble in the third quarter worth about $33,000. New Wave Wealth Advisors LLC purchased a new position in shares of Procter & Gamble in the fourth quarter worth approximately $46,000. Costello Asset Management INC grew its position in Procter & Gamble by 2,142.9% during the third quarter. Costello Asset Management INC now owns 314 shares of the company’s stock valued at $54,000 after buying an additional 300 shares during the period. William B. Walkup & Associates Inc. purchased a new stake in Procter & Gamble during the second quarter valued at approximately $58,000. Finally, Mendota Financial Group LLC raised its position in Procter & Gamble by 58.0% in the fourth quarter. Mendota Financial Group LLC now owns 376 shares of the company’s stock worth $63,000 after acquiring an additional 138 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Company Profile

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.